跳至主要内容
临床试验/NL-OMON21398
NL-OMON21398暂停不适用

The efficacy of a CBT relapse prevention program for remitted anxiety disorder patients who discontinue antidepressant medication (AD).

GGZ InGeest (partner van VUMC)0 个研究点目标入组 220 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
220

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Included are adults aged 18-65 years, who:
  • 1. Use antidepressants for panic disorder (with or without agoraphobia), social phobia or generalized anxiety disorder;

排除标准

  • Patients with comorbid dementia, psychotic disorder, alcohol or drug dependence or who do not speak Dutch are excluded.

研究者

发起方
GGZ InGeest (partner van VUMC)

相似试验